Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Emborg HD"" wg kryterium: Wszystkie pola

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 524
Tytuł:
Monitoring COVID-19 vaccine effectiveness against COVID-19 hospitalisation and death using electronic health registries in ≥65 years old population in six European countries, October 2021 to November 2022.
Autorzy:
Kislaya I; Department of Epidemiology Instituto Nacional de Saúde Doutor Ricardo Jorge (INSA) Lisbon Portugal.
Sentís A; Epidemiology Department Epiconcept Paris France.
Starrfelt J; Norwegian Institute of Public Health (NIPH) Oslo Norway.
Nunes B; Department of Epidemiology Instituto Nacional de Saúde Doutor Ricardo Jorge (INSA) Lisbon Portugal.
Martínez-Baz I; Instituto de Salud Pública de Navarra - IdiSNA Pamplona Spain.; CIBER on Epidemiology and Public Health (CIBERESP) Madrid Spain.
Nielsen KF; Department of Infectious Disease Epidemiology & Prevention Statens Serum Institut (SSI) Copenhagen Denmark.
AlKerwi A; Ministry of Health, Directorate of Health, Service Epidemiology and Statistics Luxembourg Luxembourg.
Braeye T; Epidemiology of infectious diseases, Sciensano Brussels Belgium.
Fontán-Vela M; Instituto de Salud Carlos III (ISCIII), Madrid Spain.; Public Health and Epidemiology research group School of Medicine and Health Sciences, Universidad de Alcalá, Alcalá de Henares Madrid Spain.
Bacci S; Vaccine Preventable Diseases and Immunisation European Centre for Disease Prevention and Control (ECDC) Solna Sweden.
Meijerink H; Norwegian Institute of Public Health (NIPH) Oslo Norway.
Castilla J; Instituto de Salud Pública de Navarra - IdiSNA Pamplona Spain.; CIBER on Epidemiology and Public Health (CIBERESP) Madrid Spain.
Emborg HD; Department of Infectious Disease Epidemiology & Prevention Statens Serum Institut (SSI) Copenhagen Denmark.
Hansen CH; Department of Infectious Disease Epidemiology & Prevention Statens Serum Institut (SSI) Copenhagen Denmark.
Schmitz S; Ministry of Health, Directorate of Health, Service Epidemiology and Statistics Luxembourg Luxembourg.
Van Evercooren I; Epidemiology of infectious diseases, Sciensano Brussels Belgium.
Valenciano M; Epidemiology Department Epiconcept Paris France.
Nardone A; Epidemiology Department Epiconcept Paris France.
Nicolay N; Vaccine Preventable Diseases and Immunisation European Centre for Disease Prevention and Control (ECDC) Solna Sweden.
Monge S; Instituto de Salud Carlos III (ISCIII), Madrid Spain.; CIBER on Infectious Diseases (CIBERINFEC) Madrid Spain.
Pokaż więcej
Corporate Authors:
VEBIS‐Lot4 working group
Źródło:
Influenza and other respiratory viruses [Influenza Other Respir Viruses] 2023 Nov; Vol. 17 (11), pp. e13195.
Typ publikacji:
Meta-Analysis; Journal Article
MeSH Terms:
COVID-19 Vaccines*
COVID-19*/epidemiology
COVID-19*/prevention & control
Humans ; Aged ; Vaccine Efficacy ; Registries ; Electronics ; Hospitalization
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Sociodemographic differences in Covid-19 vaccine uptake in Denmark: a nationwide register-based cohort study.
Autorzy:
Gram MA; Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, 5 Artillerivej, 2300, Copenhagen S, Denmark. .
Moustsen-Helms IR; Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, 5 Artillerivej, 2300, Copenhagen S, Denmark.
Valentiner-Branth P; Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, 5 Artillerivej, 2300, Copenhagen S, Denmark.
Emborg HD; Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, 5 Artillerivej, 2300, Copenhagen S, Denmark.
Pokaż więcej
Źródło:
BMC public health [BMC Public Health] 2023 Feb 24; Vol. 23 (1), pp. 391. Date of Electronic Publication: 2023 Feb 24.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19 Vaccines*
COVID-19*
Humans ; Cohort Studies ; SARS-CoV-2 ; Denmark
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Vaccine effectiveness against SARS-CoV-2 reinfection during periods of Alpha, Delta, or Omicron dominance: A Danish nationwide study.
Autorzy:
Nielsen KF; Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark.
Moustsen-Helms IR; Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark.
Schelde AB; Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark.
Gram MA; Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark.
Emborg HD; Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark.
Nielsen J; Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark.
Hansen CH; Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark.
Andersen MA; Department of Data Integration and Analysis, Statens Serum Institut, Copenhagen, Denmark.
Meaidi M; Department of Data Integration and Analysis, Statens Serum Institut, Copenhagen, Denmark.
Wohlfahrt J; Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark.
Valentiner-Branth P; Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark.
Pokaż więcej
Źródło:
PLoS medicine [PLoS Med] 2022 Nov 22; Vol. 19 (11), pp. e1004037. Date of Electronic Publication: 2022 Nov 22 (Print Publication: 2022).
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*/epidemiology
COVID-19*/prevention & control
Viral Vaccines*
Humans ; SARS-CoV-2 ; Reinfection/epidemiology ; Reinfection/prevention & control ; COVID-19 Vaccines/therapeutic use ; Vaccine Efficacy ; Denmark/epidemiology
SCR Organism:
SARS-CoV-2 variants
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study.
Autorzy:
Gram MA; Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark.
Emborg HD; Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark.
Schelde AB; Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark.
Friis NU; Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark.
Nielsen KF; Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark.
Moustsen-Helms IR; Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark.
Legarth R; Division of Infectious Disease Preparedness, Data Integration and Analysis, Statens Serum Institut, Copenhagen, Denmark.
Lam JUH; Division of Infectious Disease Preparedness, Data Integration and Analysis, Statens Serum Institut, Copenhagen, Denmark.
Chaine M; Division of Infectious Disease Preparedness, Data Integration and Analysis, Statens Serum Institut, Copenhagen, Denmark.
Malik AZ; Division of Infectious Disease Preparedness, Data Integration and Analysis, Statens Serum Institut, Copenhagen, Denmark.
Rasmussen M; Department of Virus Research and Development Laboratory, Virus and Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark.
Fonager J; Department of Virus Research and Development Laboratory, Virus and Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark.
Sieber RN; Department of Bacteria, Parasites, and Fungi, Statens Serum Institut, Copenhagen, Denmark.
Stegger M; Department of Bacteria, Parasites, and Fungi, Statens Serum Institut, Copenhagen, Denmark.
Ethelberg S; Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark.; Department of Public Health, Global Health Section, University of Copenhagen, Copenhagen, Denmark.
Valentiner-Branth P; Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark.
Hansen CH; Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark.; MRC International Statistics and Epidemiology Group, Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, United Kingdom.
Pokaż więcej
Źródło:
PLoS medicine [PLoS Med] 2022 Sep 01; Vol. 19 (9), pp. e1003992. Date of Electronic Publication: 2022 Sep 01 (Print Publication: 2022).
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*/epidemiology
COVID-19*/prevention & control
Viral Vaccines*
BNT162 Vaccine ; Cohort Studies ; Denmark/epidemiology ; Hospitalization ; Humans ; SARS-CoV-2/genetics ; Vaccine Efficacy
SCR Organism:
SARS-CoV-2 variants
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Vaccine effectiveness against SARS-CoV-2 infection, hospitalization, and death when combining a first dose ChAdOx1 vaccine with a subsequent mRNA vaccine in Denmark: A nationwide population-based cohort study.
Autorzy:
Gram MA; Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark.
Nielsen J; Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark.
Schelde AB; Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark.
Nielsen KF; Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark.
Moustsen-Helms IR; Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark.
Sørensen AKB; Department of Infectious Disease Preparedness, Data Integration and Analysis, Statens Serum Institut, Copenhagen, Denmark.
Valentiner-Branth P; Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark.
Emborg HD; Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark.
Pokaż więcej
Źródło:
PLoS medicine [PLoS Med] 2021 Dec 17; Vol. 18 (12), pp. e1003874. Date of Electronic Publication: 2021 Dec 17 (Print Publication: 2021).
Typ publikacji:
Journal Article; Observational Study
MeSH Terms:
SARS-CoV-2*
BNT162 Vaccine/*administration & dosage
COVID-19/*immunology
COVID-19/*prevention & control
ChAdOx1 nCoV-19/*administration & dosage
Adult ; Comorbidity ; Denmark ; Female ; Hospitalization ; Humans ; Male ; Middle Aged ; Risk ; Treatment Outcome ; Vaccination ; Vaccine Efficacy
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Antigenic drift and immunity gap explain reduction in protective responses against influenza A(H1N1)pdm09 and A(H3N2) viruses during the COVID-19 pandemic: a cross-sectional study of human sera collected in 2019, 2021, 2022, and 2023.
Autorzy:
Fossum, Even (AUTHOR)
Rohringer, Andreas (AUTHOR)
Aune, Torstein (AUTHOR)
Rydland, Kjersti Margrethe (AUTHOR)
Bragstad, Karoline (AUTHOR)
Hungnes, Olav (AUTHOR)
Pokaż więcej
Źródło:
Virology Journal. 3/6/2024, Vol. 21 Issue 1, p1-14. 14p.
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Multidrug resistance among uropathogenic clonal group A E. Coli isolates from Pakistani women with uncomplicated urinary tract infections.
Autorzy:
Khan, Ayesha (AUTHOR)
Saraf, Viqar Sayeed (AUTHOR)
Siddiqui, Fariha (AUTHOR)
Batool, Tahira (AUTHOR)
Noreen, Zobia (AUTHOR)
Javed, Sundus (AUTHOR)
Ahmad, Aftab (AUTHOR)
Alonazi, Wadi B. (AUTHOR)
Ibrahim, Muhammad (AUTHOR)
Pucciarelli, Sandra (AUTHOR)
Bokhari, Habib (AUTHOR)
Pokaż więcej
Źródło:
BMC Microbiology. 3/7/2024, Vol. 24 Issue 1, p1-12. 12p.
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Resurgence of Respiratory Syncytial Virus in the Summer of 2021 in Denmark—a Large out-of-season Epidemic Affecting Older Children.
Autorzy:
Lomholt, Frederikke Kristensen (AUTHOR)
Emborg, Hanne-Dorthe (AUTHOR)
Nørgaard, Sarah Kristine (AUTHOR)
Nielsen, Jens (AUTHOR)
Munkstrup, Charlotte (AUTHOR)
Møller, Karina Lauenborg (AUTHOR)
Krog, Jesper Schak (AUTHOR)
Trebbien, Ramona (AUTHOR)
Vestergaard, Lasse Skafte (AUTHOR)
Pokaż więcej
Źródło:
Open Forum Infectious Diseases. Mar2024, Vol. 11 Issue 3, p1-8. 8p.
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Vaccine effectiveness against influenza hospitalisation in adults during the 2022/2023 mixed season of influenza A(H1N1)pdm09, A(H3N2) and B circulation, Europe: VEBIS SARI VE hospital network.
Autorzy:
Rose, Angela M. C. (AUTHOR)
Pozo, Francisco (AUTHOR)
Martínez‐Baz, Iván (AUTHOR)
Mazagatos, Clara (AUTHOR)
Bossuyt, Nathalie (AUTHOR)
Cauchi, John Paul (AUTHOR)
Petrović, Goranka (AUTHOR)
Loghin, Isabela I. (AUTHOR)
Vaikutyte, Roberta (AUTHOR)
Buda, Silke (AUTHOR)
Machado, Ausenda (AUTHOR)
Duffy, Róisín (AUTHOR)
Oroszi, Beatrix (AUTHOR)
Howard, Jennifer (AUTHOR)
Echeverria, Aitziber (AUTHOR)
Andreu, Cristina (AUTHOR)
Barbezange, Cyril (AUTHOR)
Džiugytė, Aušra (AUTHOR)
Nonković, Diana (AUTHOR)
Popescu, Corneliu‐Petru (AUTHOR)
Pokaż więcej
Źródło:
Influenza & Other Respiratory Viruses. Feb2024, Vol. 18 Issue 2, p1-9. 9p.
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Estimation of vaccination coverage from electronic healthcare records; methods performance evaluation - A contribution of the ADVANCE-project.
Autorzy:
Braeye T; Sciensano, Brussels, Belgium.; Hasselt University, Hasselt, Belgium.
Bauchau V; GSK Vaccines, Wavre, Belgium.
Sturkenboom M; P95 Epidemiology and Pharmacovigilance, Leuven, Belgium.; VACCINE.GRID foundation, Basel, Switzerland.; University Medical Center Utrecht, Julius Global Health, Utrecht, the Netherlands.
Emborg HD; Statens Serum Institut, Copenhagen, Denmark.
García AL; BIFAP database, Spanish Agency of Medicines and Medical Devices, Madrid, Spain.
Huerta C; BIFAP database, Spanish Agency of Medicines and Medical Devices, Madrid, Spain.
Merino EM; BIFAP database, Spanish Agency of Medicines and Medical Devices, Madrid, Spain.
Bollaerts K; P95 Epidemiology and Pharmacovigilance, Leuven, Belgium.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2019 Sep 18; Vol. 14 (9), pp. e0222296. Date of Electronic Publication: 2019 Sep 18 (Print Publication: 2019).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Electronic Health Records/*economics
Vaccination/*economics
Vaccination Coverage/*economics
Europe ; Humans ; Papillomaviridae/immunology ; Pertussis Vaccine/economics ; Risk Assessment/economics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Influenza vaccine effectiveness in Europe: Results from the 2022–2023 VEBIS (Vaccine Effectiveness, Burden and Impact Studies) primary care multicentre study.
Autorzy:
Maurel, Marine (AUTHOR)
Pozo, Francisco (AUTHOR)
Pérez‐Gimeno, Gloria (AUTHOR)
Buda, Silke (AUTHOR)
Sève, Noémie (AUTHOR)
Oroszi, Beatrix (AUTHOR)
Hooiveld, Mariette (AUTHOR)
Gomez, Verónica (AUTHOR)
Domegan, Lisa (AUTHOR)
Martínez‐Baz, Iván (AUTHOR)
Ilić, Maja (AUTHOR)
Carnahan, Anna Sara (AUTHOR)
Mihai, Maria Elena (AUTHOR)
Martínez, Ana (AUTHOR)
Goerlitz, Luise (AUTHOR)
Enouf, Vincent (AUTHOR)
Horváth, Judit Krisztina (AUTHOR)
Dijkstra, Frederika (AUTHOR)
Rodrigues, Ana Paula (AUTHOR)
Bennett, Charlene (AUTHOR)
Pokaż więcej
Źródło:
Influenza & Other Respiratory Viruses. Jan2024, Vol. 18 Issue 1, p1-12. 12p.
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Prevalence of Streptococcus agalactiae in Urinary Tract Infections of Pregnant Women.
Autorzy:
Saghabashi, Ahdiyeh
Rostami, Khadijeh
Allameh, Maryam
Khaledi, Mansoor
Afkhami, Hamed
Fathi, Javad
Parvizi, Rahmatullah
Esmkhani, Mohammad
Zadegan Dezfuli, Aram Asareh
Shahriary, Shamin
Mahjoor, Mohamad
Pokaż więcej
Źródło:
Journal of Medical Bacteriology. 2024, Vol. 12 Issue 1, p25-32. 8p.
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Evolution of Influenza A(H3N2) Viruses in 2 Consecutive Seasons of Genomic Surveillance, 2021–2023.
Autorzy:
Fall, Amary (AUTHOR)
Han, Lijie (AUTHOR)
Yunker, Madeline (AUTHOR)
Gong, Yu-Nong (AUTHOR)
Li, Tai-Jung (AUTHOR)
Norton, Julie M (AUTHOR)
Abdullah, Omar (AUTHOR)
Rothman, Richard E (AUTHOR)
Fenstermacher, Katherine Z J (AUTHOR)
Morris, C Paul (AUTHOR)
Pekosz, Andrew (AUTHOR)
Klein, Eili (AUTHOR)
Mostafa, Heba H (AUTHOR)
Pokaż więcej
Źródło:
Open Forum Infectious Diseases. Dec2023, Vol. 10 Issue 12, p1-9. 9p.
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Long-term vaccination strategies to mitigate the impact of SARS-CoV-2 transmission: A modelling study.
Autorzy:
Hogan, Alexandra B. (AUTHOR)
Wu, Sean L. (AUTHOR)
Toor, Jaspreet (AUTHOR)
Olivera Mesa, Daniela (AUTHOR)
Doohan, Patrick (AUTHOR)
Watson, Oliver J. (AUTHOR)
Winskill, Peter (AUTHOR)
Charles, Giovanni (AUTHOR)
Barnsley, Gregory (AUTHOR)
Riley, Eleanor M. (AUTHOR)
Khoury, David S. (AUTHOR)
Ferguson, Neil M. (AUTHOR)
Ghani, Azra C. (AUTHOR)
Pokaż więcej
Źródło:
PLoS Medicine. 11/28/2023, Vol. 20 Issue 11, p1-24. 24p.
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Factors underlying COVID-19 booster vaccine uptake among adults in Belgium.
Autorzy:
Vermeiren, Elias (AUTHOR)
van Loenhout, Joris A. F. (AUTHOR)
Nasiadka, Léonore (AUTHOR)
Stouten, Veerle (AUTHOR)
Billuart, Matthieu (AUTHOR)
Van Evercooren, Izaak (AUTHOR)
Catteau, Lucy (AUTHOR)
Hubin, Pierre (AUTHOR)
Pokaż więcej
Źródło:
BMC Research Notes. 11/11/2023, Vol. 16 Issue 1, p1-6. 6p.
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 524

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies